BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN BEGIN:VTIMEZONE TZID:UTC BEGIN:STANDARD DTSTART;VALUE=DATE:20250101 TZNAME:UTC TZOFFSETFROM:+0000 TZOFFSETTO:+0000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:\n\n\n\n\n\n\n\n\nDate: Tuesday 29th March 2022\nTime: 12:00-13 :00 BST\nSpeakers: Amanda Darekar (Pfizer)\, Joanne Mann (Veramed) and Hol ly Tovey (Institute for Cancer Research). \;\n\nWho is this event inte nded for? \;Statisticians at all levels.\nWhat is the benefit of atten ding? \;Learn about different career trajectories from Statisticians a cross the healthcare industry and expand your view on the role of 'Statist ician'. \;\nRegistration\nRegistration for this webinar is free\, and is open to Members of PSI only.\nTo register for this event\, please \ ;click here.\nOverview\nClimbing the traditional Career Ladder has long be en associated with career progression with the ultimate goal of moving int o management. Statistics as a field has grown in prominence\, especially i n the last few years and with that growth we re-examine whether the tradit ional Career Ladder is still relevant. \;\n\nHear from others in the P SI Community who look to forge their own path in the industry as a Statist ician. They will give their own personal views and experiences on creating your own career path.\nSpeaker details\n\n\n\n \n \n \n Speaker\n \n \n Biography\ n \n \n \n \n \n Joanne Mann\n (Veramed)\n \n \n Joanne is a Principal level Statistician working at Veramed. She has ov er 25 years experience in the Pharmaceutical Industry\, working as a proje ct statistician and in project statistical oversight for Contract Research Organisations (including Covance\, PharmaNet and inVentiv Health) and mor e recently for Pharma companies such as Eli Lilly. She has experience with in both early and late phase clinical trials\, and in a wide range of ther apeutic areas including oncology. \n  \;\n \n \n \n \n \n Amanda Darekar\n (Pfizer)\n \n \n Amanda has ne arly 25 years&rsquo\; experience in the industry. She started her career a t Quintiles (now IQVIA) supporting a wide range of clients and projects\, followed by a stint at Pharmacia\, a mid-size pharmaceutical company\, mov ing to Pfizer after its acquisition of Pharmacia in 2003. \n Si nce then\, Amanda has supported a wide range of projects spanning many the rapeutic areas and phases\, initially working on early development studies in neurology/pain and urology\, and in 2007 Amanda undertook a year-long secondment to Pfizer India to manage a statistics group in Mumbai. Once ba ck in the UK\, she returned to supporting a variety of projects within uro logy and cardiovascular/metabolic therapeutic areas. Amanda is currently s tatistical program lead for two projects within the Internal Medicine Stat istics Cluster.\n  \;\n \n \n \n \n \n Holly Tovey\n (Institute of Cancer Research)\n \n \n Holly Tovey i s a senior statistician and PhD student in the Clinical Trials and Statist ics Unit at the Institute of Cancer Research. The aim of her thesis is the identification of biomarkers to predict response for emerging therapeutic agents for triple negative breast cancer. Her main areas of interest are machine learning and effective incorporation of biomarkers in clinical tri als. \n  \;\n \n \n \n\n \; DTEND:20220329T120000Z DTSTAMP:20260912T162048Z DTSTART:20220329T110000Z LOCATION: SEQUENCE:0 SUMMARY:PSI Careers - Lunch & Learn: The Floating Ladder UID:RFCALITEM639248268486605698 X-ALT-DESC;FMTTYPE=text/html:Logo resized
\n
\n
\n
\n
\n
\n
\n
\ n
\nDate: Tuesday 29th March 2022
\nTim e: 12:00-13:00 BST
\nSpeakers: Amanda Darek ar (Pfizer)\, Joanne Mann (Veramed) and Holly Tovey (Institute for Cancer Research). \;
\n
\nWho is this event intended for? \;Statisticians at all levels.
\nWhat is the benefit of attending? \;Learn about di fferent career trajectories from Statisticians across the healthcare indus try and expand your view on the role of 'Statistician'. \;
\n

Registration

\n

Registration for this webinar is free\, and is open to Members of PSI only.
\nTo register for this event\, please \;< strong>click here.

\n

O verview

\n

Climbing the traditional Career Ladder has long been asso ciated with career progression with the ultimate goal of moving into manag ement. Statistics as a field has grown in prominence\, especially in the l ast few years and with that growth we re-examine whether the traditional C areer Ladder is still relevant. \;
\n
\nHear from others in the PSI Community who look to forge their own path in the industry as a St atistician. They will give their own personal views and experiences on cre ating your own career path.

\n

Speaker details

\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
\n

Speaker

\n 		\n

Biography

\n < /td>\n
\n

Joanneedit
\n Joa nne Mann
\n (Veramed)

\n 		\n

Joanne i s a Principal level Statistician working at Veramed. She has over 25 years experience in the Pharmaceutical Industry\, working as a project statisti cian and in project statistical oversight for Contract Research Organisati ons (including Covance\, PharmaNet and inVentiv Health) and more recently for Pharma companies such as Eli Lilly. She has experience within both ear ly and late phase clinical trials\, and in a wide range of therapeutic are as including oncology.

\n

 \;

\n
\n

Amandaedit
\n Amanda Darekar
\n (Pfizer)

\n 		\n

Amanda has nearly 25 years&rsquo\; experience in the industry. She started her caree r at Quintiles (now IQVIA) supporting a wide range of clients and projects \, followed by a stint at Pharmacia\, a mid-size pharmaceutical company\, moving to Pfizer after its acquisition of Pharmacia in 2003.

\n

Since then\, Amanda has supported a wide range of projects spannin g many therapeutic areas and phases\, initially working on early developme nt studies in neurology/pain and urology\, and in 2007 Amanda undertook a year-long secondment to Pfizer India to manage a statistics group in Mumba i. Once back in the UK\, she returned to supporting a variety of projects within urology and cardiovascular/metabolic therapeutic areas. Amanda is c urrently statistical program lead for two projects within the Internal Med icine Statistics Cluster.

\n

 \;

\n \n
\n

Hollyedit
\n Holly To vey
\n (Institute of Cancer Research)

\n 		\n

Holly Tovey is a senior statistician and PhD student in the Clinic al Trials and Statistics Unit at the Institute of Cancer Research. The aim of her thesis is the identification of biomarkers to predict response for emerging therapeutic agents for triple negative breast cancer. Her main a reas of interest are machine learning and effective incorporation of bioma rkers in clinical trials.

\n

 \;

\n \n
\n

 \;

END:VEVENT END:VCALENDAR